Drug Approval | November 04, 2023
Lupin receives tentative approval from USFDA for Selexipag for injection
This product will be manufactured at Lupin's Nagpur facility in India
This product will be manufactured at Lupin's Nagpur facility in India
In 2022, darolutamide was FDA-approved in combination with docetaxel chemotherapy for adults with metastatic hormone-sensitive prostate cancer
Lyka Labs has reported total income of Rs. 28.23 crores during the period ended September 30, 2023
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
NATCO's Pharmacovigilance Department was inspected from October 30, 2023 to November 1, 2023
The inspection of the facility conducted from August 7 to August 11, 2023
Revenue in the three months ended on Oct. 1 also slipped by 42% to US$ 13.23 billion
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
The European Commission approved the use of Carbopol as an additive for liquid and solid food supplements in the EU
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
Subscribe To Our Newsletter & Stay Updated
